JOURNAL OF CLINICAL SURGERY ›› 2023, Vol. 31 ›› Issue (2): 127-131.doi: 10.3969/j.issn.1005-6483.2023.02.008

Previous Articles     Next Articles

Risk factors of recurrence in patients with residual tumor after transurethral resection of bladder tumor for non muscular invasive bladder cancer

  

  1. Department of Urology,Taihe hospital,Hubei Province,Shiyan City 442000,China
  • Received:2022-07-09 Revised:2022-07-09 Accepted:2022-07-09 Online:2023-02-20 Published:2023-02-20

Abstract: Objective To explore the risk factors of recurrence in patients with residual tumor after transurethral resection of bladder tumor (TURBT) for non muscle invasive bladder cancer.Methods The medical records of 100 patients with residual tumor after TURBT for non muscular invasive bladder cancer treated in our hospital from May 2020 to June 2021 were retrospectively analyzed.The patients were followed up for 12 months,and were divided into recurrence group(15 cases) and non recurrence group(85 cases).Multivariate logistic regression analysis was used to analyze the risk factors of recurrence in patients with non myometrial invasive bladder cancer after secondary resection.Nomogram nomogram model was established,and the working characteristic curve of subjects was drawn to analyze the predictive efficacy.Results 100 cases of non myometrial invasive bladder cancer were followed up for 12 months and 15 cases recurred.The 1-year recurrence rate was 15.00%.The proportion of multiple tumors,tumor stage T1 and low differentiation of tumor in the recurrent group before the first TURBT was higher than that in the non recurrent group,and the proportion of BCG perfusion after tumor pedicle and secondary resection was lower than that in the non recurrent group (P<0.05).The results of logistic regression analysis showed that multiple tumors,tumor stage T1 and low differentiation before the first TURBT were the risk factors for recurrence after the second resection (P<0.05).BCG infusion was the protective factor of recurrence after secondary resection (P<0.05).The area under the curve (AUC) of nomograph prediction model for predicting recurrence after secondary resection of non myometrial invasive bladder cancer was 0.759 (95%CI:0.641 ~ 0.827).Conclusion Multiple tumors before the first TURBT,tumor stage T1 and tumor low differentiation are the risk factors for recurrence after the second resection.BCG perfusion after the second resection is the protective factor for recurrence after the second resection.The establishment of nomogram model can be used to intuitively and comprehensively evaluate the risk of recurrence after the second resection.

Key words: non muscular invasive bladder cancer, transurethral resection of bladder tumor, secondary electrotomy, recurrence, risk factors

[1] CHEN Yongwei, LI Hao, HUANG Li, et al. Effects of neoadjuvant chemotherapy combined with transurethral resection of bladder tumor on tumor diameter,urine BTA level and recurrence rate in patients with bladder cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 152-155.
[2] GUO jia, ZHU Chuanxiang, HE Wei. Feasibility study about ligation of the intersphincteric fistula tract with endorectal advancement flap in the treatment of high complex anal fistula [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(1): 74-76.
[3] MO Bo, WANG Pei, TONG Yixin, et al. Analysis of the effects of membrane anatomy in radical resection of gastric cancer on reducing complications [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(9): 835-838.
[4] PENG Qiwang, DENG Hao, LI Wei. Construction and analysis of early postoperative recurrence risk prediction model for gastric cancer patients based on LncRNA expression [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(9): 848-851.
[5] WU Yongli, FANG Hangang, CHEN Jing, et al. Relationship between preoperative peripheral blood miR-21,VEGF,CA19-9 and clinical staging,postoperative recurrence,metastasis in patients with colorectal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 771-774.
[6] GUAN Yan, ZHANG Guojiao, LUO Yin. Establishment and validation of early enteral nutrition aspiration risk prediction model for patients with severe acute pancreatitis based on machine learning algorithm [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(7): 634-638.
[7] LIU Bohao , ZHANG Yanpeng, TAO Runyi, et al. Analysis of postoperative recurrence of thoracic wall malignant tumor [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 331-334.
[8] ZHANG Chuanzhuo , REN Ming, MENG Dali, et al. Risk factors analysis of lateral cervical lymph node metastasis in medullary thyroid carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 230-233.
[9] XIANG Xuan , Wufuer·Yimaer, WANG Huguo. Risk factors associated with parathyroid injury after thyroidectomy:A Metaanalysis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 234-238.
[10] ZHANG Fengduo, CHEN Xiaodong, WU Zeyu. Study on serum HIF-1 α and IL-6 expression in predicting the recurrence of elderly patients with pituitary adenomas after the treatment of transsphenoidal surgery [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 142-144.
[11] LI Xinqian, CHEN Chuang, SUN Shengrong. The effect of surgical and non-surgical treatment on granulomatous lobular mastitis and the risk factors for recurrence [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 145-148.
[12] ZHAO Shuo, DANG Chengxue, LI Wenxing, et al. Analysis of risk factors for anastomotic Leakage of esophageal cancer patients after radical esophagectomy [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 161-164.
[13] GUAN Yan, HE Linyu, LUO Yin. Construction and validation of risk prediction model for infectious complications after hepatectomy in patients with intrahepatic bile duct stones [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 182-185.
[14] XU Weijie, LI Jinyu, LIN Lianzheng, et al.. Effect of transurethral plasma ERBT on blood loss and oxidative stress factors in patients with NMIBC [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(12): 1187-1190.
[15] YE Wenqian, ZHOU Pengyuan, WANG Ping. Study on the value of imaging risk factors in guiding operation and predicting postoperative complications of abdominal neuroblastoma in children [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(10): 935-939.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 802 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(5): 366 -0 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(5): 386 -0 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2017, 25(2): 85 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2017, 25(4): 301 .
[6] LIU Mingxin, XU Jianjun. Analysis of causes and treatment of iatrogenic bile duct injury[J]. JOURNAL OF CLINICAL SURGERY, 2018, 26(10): 777 -779 .
[7] WANG Guoyi, LIANG Jianfeng, TIAN Jinlin, et al. Clinical efficacy comparison of endoscopic and Xray placement of stenting in treatment of advanced esophageal and cardiac cancer[J]. JOURNAL OF CLINICAL SURGERY, 2018, 26(9): 679 -682 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2018, 26(9): 709 -711 .
[9] LIN Peida, HUANG Jiaqi, LU Huaxiang, et al. Safety and early efficacy analysis of pharmacomechanical thrombectomy for the treatment of trauma patients with lower extremity deep venous thrombosis[J]. JOURNAL OF CLINICAL SURGERY, 2018, 26(11): 810 -813 .
[10] HAN Yanlong, ZHANG Cheng, CHEN Dongming, et al.. Endoscopic surgical treatment of 52 cases of prolactinoma[J]. JOURNAL OF CLINICAL SURGERY, 2018, 26(11): 831 -834 .